Skip to content
Open access

From "wish-list" to successful delivery: Opportunities for multidisciplinary and multisectoral engagement in implementation of strategies to phase out animal testing.

Aug 2026 · Integrated Environmental Assessment and Management · 0 citations
Medicine

Abstract

Regulatory agencies worldwide are calling for New Approach Methods (NAMs) that reduce reliance on vertebrate animal testing in toxicological risk assessment and related regulatory decision-making. In this Brief Communication, we consider three recent examples of holistic strategies that support the development, validation, and uptake of NAMs in regulatory settings, namely the 'Strategy to replace, reduce or refine vertebrate animal testing under the Canadian Environmental Protection Act, 1999 (CEPA)', the 'Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods' in the United Kingdom, and the 'Roadmap towards phasing out animal testing for chemical safety assessments' from the European Union. The development, consultation on, and publication of these strategies represent an important step forward in the regulatory adoption of NAMs. We aim to interpret and highlight commonalities and differences between these strategies to identify the themes and actions being proposed to eliminate NAM obstacles and enhance NAM drivers in different regulatory settings. Further, we consider some of the challenges that may lay ahead in the effective implementation and delivery of these strategies, including 1) Sustaining commitment to delivery of aspirational plans, 2) Increasing engagement in regulatory processes by NAM developers, and 3) Increasing the regulatory relevance of NAM data.

Read PDF

Similar papers

Review Open access Sep 2026

Strategic Application of New Approach Methodologies (NAMs) in Fragrance Ingredient Safety Assessment: Integration of In Vitro, In Silico, and Exposure-Based Approaches in RIFM Evaluations.

New Approach Methodologies (NAMs) are transforming toxicological risk assessment by providing human-relevant, non-animal approaches for hazard identification, exposure assessment, and safety evaluation. This manuscript presents an overview of the Research Institute for Fragrance Materials (RIFM) New Approach Methodolog...

I. Lee, A. Api, A. Bartlett et al. · 1 citation
Open access 2026

Drug safety assessment within a sustainable development framework

The pharmaceutical sciences are inherently part of Goal no. 3 of the 17 United Nation's Sustainable Development Goals (SDGs) of the 2030 Agenda for Sustainable Development: "ensure healthy lives and promote well-being for all at all ages". This concept includes challenges in the process of designing and manufacturing m...

B. Antonijević · 0 citations
Review Open access Sep 2026

Model building a national human biomonitoring programme from the ground up: A framework informed by a comprehensive review of global state-of-the-art practices.

Global chemical production is projected to increase sharply by 2050, intensifying concerns about population exposure and related health and environmental risks. Human biomonitoring (HBM) provides a direct measure of aggregate internal exposure to chemicals and can act as an early warning tool for emerging health risks....

Richa Singh, H. Koch, M. Kolossa-Gehring et al. · 0 citations
Review Sep 2026

Horizon Scanning to Identify Emerging Environmental Health Concerns: Community-Based Strategies to Shift from Reactive to Proactive Approaches.

Emerging environmental threats increasingly challenge public health systems, and these risks often outpace the ability of scientists and policymakers to respond effectively. To address this gap, horizon scanning offers a proactive approach to identify early signals of potential threats, enabling timely research and pol...

Kirsten E. Overdahl, C. Blystone, H. Cunny et al. · 0 citations
Review Oct 2026

New Approach Methodologies in Pharmaceutical Development: Survey Insights on Adoption, Infrastructure, and the Path to Broader Implementation.

New approach methodologies (NAMs) have long contributed to pharmaceutical development with growing attention now focused on their use at regulatory decision points to reduce reliance on laboratory animal models in drug safety and efficacy assessment. Yet validated NAMs remain limited to specific endpoints, and uncertai...

Jessica C. Graham, Brandy Morenko, Damodaran Annamalai et al. · 0 citations
Review Open access Sep 2026

Best Practices for the Development, Implementation, and Sustainment of Exposure Registries: A Rapid Review

The objective of this rapid review was to synthesize lessons learned from past exposure registries developed in response to environmental and occupational exposure events and provide guidance for the development and implementation of future exposure registries. A rapid review was conducted following the Preferred Repor...

Paola I. Rocha Romo, Rachel F. Durnin, Jeffrey D. Freeman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.